Zepp Health Corporation
NYSE:ZEPPConsumer Electronics
Technology
$3.55 -0.58%
-$0.03 today
- Market cap
- $50.84M
- Beta
- 1.78
- P/E (TTM)
- -0.1
- EPS (TTM)
- -$282.07
52W Low $2.36High $61.85
Volume 0.04M
Average 0.13M
Balance Sheet
Inspect the capital base behind the business.
Assets
$3.95B
FY 2025 · Annual
+2.4% YoYLiabilities
$2.45B
FY 2025 · Annual
+21.7% YoYEquity
$1.50B
FY 2025 · Annual
-18.7% YoYBalance Sheet
CNY
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.51B | 959.38M | 995.09M | 808.23M | 789.7M |
| Short-term Investments | 24.32M | 33.82M | 36.5M | 7.28M | 0 |
| Net Receivables | 1.09B | 857.83M | 580.63M | 577.66M | 514.47M |
| Inventory | 1.26B | 1.01B | 601.38M | 414.51M | 508.76M |
| Other Current Assets | 815.05K | 3.17M | 1.63M | 1.7M | 239.59M |
| Total Current Assets | 3.93B | 2.92B | 2.24B | 1.84B | 2.05B |
| Property, Plant & Equipment (Net) | 242.02M | 163.79M | 111.56M | 75.59M | 53.28M |
| Goodwill | 60.98M | 65.13M | 67.87M | 69.93M | 67M |
| Intangible Assets | 135.42M | 121.53M | 69.91M | 51.76M | 95.18M |
| Long-term Investments | 1.55B | 1.67B | 1.71B | 1.66B | 1.55B |
| Tax Assets | 143.25M | 207.17M | 229.53M | 127.47M | 110.08M |
| Other Non-current Assets | 19.57M | 49.67M | 68.7M | 33.63M | 26M |
| Total Non-current Assets | 2.15B | 2.28B | 2.26B | 2.02B | 1.9B |
| Total Assets | 6.08B | 5.19B | 4.5B | 3.86B | 3.95B |
| Account Payables | 1.32B | 450.04M | 264.14M | 372.8M | 564.78M |
| Short-term Debt | 550.43M | 996.26M | 513.98M | 765.56M | 1.17B |
| Tax Payables | 2.6M | 2.72M | 3.64M | 4.16M | 0 |
| Deferred Revenue | 92.1M | 62.39M | 55.51M | 37.54M | 531.44K |
| Other Current Liabilities | 146.82M | 107.87M | 244.39M | 232.37M | 266.99M |
| Total Current Liabilities | 2.15B | 1.64B | 1.1B | 1.43B | 2.01B |
| Long-term Debt | 726M | 674.4M | 850.23M | 549.17M | 415.89M |
| Deferred Tax Liabilities | 26.88M | 35.04M | 29.53M | 22.75M | 18.69M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 174.85M | 160.27M | 1.91M | 970.73K | 1.46M |
| Total Non-current Liabilities | 998.75M | 900.94M | 904.32M | 587.54M | 443.75M |
| Total Liabilities | 3.15B | 2.55B | 2B | 2.01B | 2.45B |
| Common Stock | 158.81K | 159.67K | 184.19K | 189.76K | 181.81K |
| Retained Earnings | 1.27B | 929.32M | 739.23M | 208.88M | (80.07M) |
| Accumulated OCI | 29.24M | 104.28M | (99.23M) | (293.25M) | (278.87M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | (14) |
| Minority Interest | 13.08M | 12.22M | 13.25M | 8.31M | 0 |
| Total Equity | 2.93B | 2.65B | 2.5B | 1.84B | 1.5B |
| Total Debt | 1.35B | 1.7B | 1.39B | 1.33B | 1.59B |
| Net Debt | (160.3M) | 742.51M | 391.76M | 521.15M | 804.83M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $709.9M |
| Receivables | $429.5M |
| Inventory | $432.5M |
| Other Current | $212.5M |
| Total Current Assets | $1.8B |
| PP&E (Net) | $54.5M |
| Goodwill | $65.9M |
| Intangible Assets | $90.9M |
| Long-term Investments | $1.5B |
| Tax Assets | $108.8M |
| Other Non-current | $24.3M |
| Total Non-current Assets | $1.9B |
| Total Assets | $3.7B |
Analysis
Selected assets total $3.7B for Latest. The largest visible component is Long-term Investments at $1.5B, about 41.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Sep 25, 2026 | |
| 6-K | 6-K filing | Sep 2, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 13, 2026 |
How much cash does ZEPP have?
Zepp Health Corporation (ZEPP) reported $789.70M in cash and equivalents in fiscal 2025.
How much debt does ZEPP carry?
Zepp Health Corporation (ZEPP) reported $1.59B of total debt, with net debt of $804.83M.
Continue the stock analysis
Jump to another research area for this company.